Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126902241 | 12690224 | 1 | I | 20160803 | 20160816 | 20160826 | 20160826 | EXP | GB-MHRA-EYC 00143637 | GB-DRREDDYS-GER/UKI/16/0082539 | DR REDDYS | 69.00 | YR | F | Y | 101.00000 | KG | 20160826 | PH | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126902241 | 12690224 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | U | U | UNKNOWN | 76133 | |||||||||
126902241 | 12690224 | 2 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | U | U | UNKNOWN | 0 | |||||||||
126902241 | 12690224 | 3 | SS | CLOMIPRAMINE | CLOMIPRAMINE | 1 | U | U | 0 | ||||||||||
126902241 | 12690224 | 4 | SS | LITHIUM CARBONATE. | LITHIUM CARBONATE | 1 | Oral | AT NIGHT | Y | U | 0 | 600 | MG | QD | |||||
126902241 | 12690224 | 5 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | U | 0 | ||||||||||
126902241 | 12690224 | 6 | SS | WARFARIN | WARFARIN | 1 | U | U | 0 | ||||||||||
126902241 | 12690224 | 7 | C | Atorvastatin | ATORVASTATIN | 1 | 0 | ||||||||||||
126902241 | 12690224 | 8 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
126902241 | 12690224 | 9 | C | NOVORAPID | INSULIN ASPART | 1 | 0 | ||||||||||||
126902241 | 12690224 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126902241 | 12690224 | 1 | Product used for unknown indication |
126902241 | 12690224 | 2 | Product used for unknown indication |
126902241 | 12690224 | 3 | Product used for unknown indication |
126902241 | 12690224 | 4 | Product used for unknown indication |
126902241 | 12690224 | 5 | Product used for unknown indication |
126902241 | 12690224 | 6 | Product used for unknown indication |
126902241 | 12690224 | 7 | Product used for unknown indication |
126902241 | 12690224 | 8 | Product used for unknown indication |
126902241 | 12690224 | 9 | Product used for unknown indication |
126902241 | 12690224 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126902241 | 12690224 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126902241 | 12690224 | Acute kidney injury | |
126902241 | 12690224 | Hypotension | |
126902241 | 12690224 | International normalised ratio abnormal | |
126902241 | 12690224 | Overdose | |
126902241 | 12690224 | Polyuria |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126902241 | 12690224 | 4 | 20160801 | 0 |